Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 697-702
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.697
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.697
Table 2 Clinical outcomes
| Parameter | Tacrolimus n = 1195 | Cyclosporine n = 640 | P-value |
| Mean glomerular filtration rate | 56 ± 19 | 46 ± 17 | 0.09 |
| Delayed graft function n (%) | 179 (15) | 115 (18) | 0.049 |
| Acute rejection (biopsy proven) n (%) | 167 (14) | 154 (24) | < 0.010 |
| Three years graft survival | 88% | 79% | < 0.010 |
| Five years graft survival | 84% | 70% | < 0.010 |
- Citation: Kamel M, Kadian M, Srinivas T, Taber D, Posadas Salas MA. Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine. World J Transplant 2016; 6(4): 697-702
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/697.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.697